TTD | Drug: D0Z2JN

Drug General Information
Drug ID	D0Z2JN
Former ID	DNC013210
Drug Name	N1,2-dibenzyl-N3-hydroxymalonamide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528703]
Structure		Download 2D MOL 3D MOL
Formula	C17H18N2O3
Canonical SMILES	C1=CC=C(C=C1)CC(C(=O)NCC2=CC=CC=C2)C(=O)NO
InChI	1S/C17H18N2O3/c20-16(18-12-14-9-5-2-6-10-14)15(17(21)19-22)11-13-7-3-1-4-8-13/h1-10,15,22H,11-12H2,(H,18,20)(H,19,21)
InChIKey	WKIMWNKNDQXNCK-UHFFFAOYSA-N
PubChem Compound ID	10709191
Target and Pathway
Target(s)	Aminopeptidase N	Target Info	Inhibitor	[528703]
BioCyc Pathway	Glutathione-mediated detoxification
KEGG Pathway	Glutathione metabolism
	Metabolic pathways
	Renin-angiotensin system
	Hematopoietic cell lineage
Pathway Interaction Database	C-MYB transcription factor network
PathWhiz Pathway	Glutathione Metabolism
Reactome	Metabolism of Angiotensinogen to Angiotensins
WikiPathways	Metabolism of Angiotensinogen to Angiotensins
	Cardiac Progenitor Differentiation
	miR-targeted genes in squamous cell - TarBase
	miR-targeted genes in muscle cell - TarBase
	miR-targeted genes in lymphocytes - TarBase
	miR-targeted genes in leukocytes - TarBase
	Glutathione metabolism
References
Ref 528703	J Med Chem. 2007 Mar 22;50(6):1322-34. Epub 2007 Feb 28.Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.
Ref 528703	J Med Chem. 2007 Mar 22;50(6):1322-34. Epub 2007 Feb 28.Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information